Dacarbazine (DTIC) plus bevacizumab (B) combination therapy in chemotherapy (CTh)-naive advanced melanoma (MM) patients (pts): A phase II study

被引:3
作者
di Pietro, A.
Ferrucci, P.
Munzone, E.
Mosconi, M.
Gandini, S.
Pari, C.
Cataldo, F.
Verrecchia, F.
Nole, F.
Testori, A.
机构
[1] European Inst Oncol, Melanoma & Muscle Cutaneous Sarcoma Div, Milan, Italy
[2] European Inst Oncol, Milan, Italy
[3] European Inst Oncol, Med Care Unit, Milan, Italy
[4] European Inst Oncol, Dept Biostat, Milan, Italy
关键词
D O I
10.1200/jco.2010.28.15_suppl.8536
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8536
引用
收藏
页数:1
相关论文
empty
未找到相关数据